Healthcare Services M&A

Last updated

Healthcare Services valuation multiples: the short answer

What multiple do healthcare services businesses sell for?

Healthcare services businesses sell for a median 3.4x SDE with under $500K of SDE, rising to 12.9x EBITDA with $10M+ of EBITDA, in Axia Growth's analysis of 290 closed Healthcare-sector sales, the sector 8 of the 12 Healthcare Services guides map to. Most of those sales sit in the under $500K SDE band, where the middle half sold for 2.7x-4.2x SDE across 182 sales. The other 4 guides map to Professional Services, Business Services, Retail and Technology, with most-traded-band medians from 3.2x to 7.4x SDE. Updated October 28, 2026.

Source: Axia Growth analysis of closed small-business sales, updated October 28, 2026. Figures are sector medians, not a valuation of any business. Methodology

Each Healthcare Services guide, the data sector its NAICS code maps to, and that sector's median multiple on its most-traded size band. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
GuideData sectorMedian multipleSize bandSales (n)Range across size bands
Dental PracticesHealthcare3.4x SDEUnder $500K SDE1823.4x SDE to 12.9x EBITDA
Physical Therapy & Rehab
Home Health & Hospice
Behavioral Health & Counseling
Dermatology & Medspa
Ambulatory Surgery Centers
Physician Practice Management (MSOs)
Labs & Diagnostics
Veterinary PracticesProfessional Services4.4x SDEUnder $500K SDE1984.4x SDE to 11.0x EBITDA
Medical Billing & Revenue Cycle ManagementBusiness Services3.2x SDEUnder $500K SDE523.2x SDE to 4.5x SDE
Pharmacy & Specialty InfusionRetail3.3x SDEUnder $500K SDE1623.3x SDE to 2.6x SDE
Healthcare IT & SoftwareTechnology7.4x SDEUnder $500K SDE1967.4x SDE to 12.0x EBITDA

Cite this answer

Healthcare services businesses sell for a median 3.4x SDE with under $500K of SDE, rising to 12.9x EBITDA with $10M+ of EBITDA, in Axia Growth's analysis of 290 closed Healthcare-sector sales, the sector 8 of the 12 Healthcare Services guides map to. Most of those sales sit in the under $500K SDE band, where the middle half sold for 2.7x-4.2x SDE across 182 sales. The other 4 guides map to Professional Services, Business Services, Retail and Technology, with most-traded-band medians from 3.2x to 7.4x SDE. Updated October 28, 2026. Source: Axia Growth, "Healthcare Services M&A", updated October 28, 2026, https://axiagrowth.com/resources/industries/healthcare

In short

Healthcare services businesses are priced on two tracks: owner-run practices and agencies on SDE, larger platforms on EBITDA, with multiples rising sharply with size. Practice-level dealmaking is contracting, with physician practice management deals down from 851 in 2021 to 105 in the first half of 2026, as reported by STAT, and state transaction-notice and corporate-practice laws, led by Oregon and California, are now a core diligence item.

Why published multiples differ

Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.

Axia Growth publishes size bands by sector, not for Healthcare Services as a whole, and does not estimate a figure for the category; the table below gives each guide's published band or says it is not yet published.

  • $191B[1]

    Global healthcare PE deal value, 2025

    Bain estimate; a record, surpassing the previous 2021 peak. Global, all healthcare segments.

  • ~$62B[1]

    Provider and related services PE deal value, 2025

    Up 57% year over year while volume stayed flat; healthcare IT drove much of the gain.

  • 105[3]

    Physician practice management deals, H1 2026

    As reported by STAT; down from a high of 851 deals in 2021. A separate industry release gives different quarterly counts (see body).

  • 15+[6]

    States with a healthcare transaction review law, mid-2025

    At least 15 states, per Health Capital Consultants.

See EBITDA & SDE multiples for Healthcare Services →

M&A activity snapshot

Healthcare private equity is running on two tracks. At the top of the market, global healthcare PE set a new record in 2025 with an estimated $191 billion in deal value, and investors announced 445 buyouts, the second-most on record. Those figures are Bain's global estimates across all healthcare segments.

Provider deals grew in value but not in count. Bain reports that provider and related services deal value jumped 57% to an estimated $62 billion in 2025, while volume remained flat. It adds that pure provider investment did not see the same acceleration as provider IT and services.

At the practice level, activity is contracting. Data reported by Fierce Healthcare shows PE healthcare deals down almost 19% in Q2 2026 versus Q2 2025. The same data puts 2026's deal count on track to be down 26.5% from 2025, which would be the lowest annual count since 2017.

Physician practice management (PPM), historically the largest roll-up category, has fallen furthest. STAT reported 851 PPM deals in 2021 and just 105 in the first half of 2026. Quarterly, there were 71 PPM deals in Q2 2026, compared to 89 in Q1 and 102 in Q4 of 2025. The two counts come from separate data releases. They do not reconcile: 89 plus 71 is 160 for the half (Axia arithmetic on the Advisory Board figures), not 105. Neither article explains the gap, so treat both as directional evidence of a steep decline rather than exact counts.

Who is buying

PE-backed management services organizations (MSOs) and dental support organizations (DSOs) remain the core buyers of independent practices. The largest example in dentistry is Heartland Dental, which affiliates with over 3,200 doctors in over 1,960 locations across 39 states and the District of Columbia and is majority owned by KKR.

Sponsor-to-sponsor buyers are the other major pool. Bain expects more than 150 sponsor-to-sponsor deals and more than $120 billion in estimated value for 2025, both record highs. Secondary sales give practice-level platforms an exit path, which keeps their add-on programs funded.

Bain describes physician group investors as moving beyond traditional buy-and-build models and toward integrated, clinician-centric approaches. Independent sponsors and search funds also pursue smaller practices, typically below the size threshold of institutional platforms.

What buyers look for

Buyers price healthcare services businesses on the durability of their clinical workforce and their regulatory standing as much as on EBITDA. The questions that recur in diligence:

  • Provider continuity. Whether revenue depends on one or two clinicians, and how long the selling physician or dentist will stay post-close.
  • Payer mix and reimbursement exposure. The share of revenue from commercial insurance, government programs, and cash pay, and how sensitive margins are to rate changes.
  • Corporate-practice compliance. Whether the existing management agreement keeps clinical decisions with licensed professionals, as state corporate-practice doctrines require.
  • Transaction-notice exposure. Whether the deal triggers a state pre-closing filing and how long review could take.

State rules now shape the structure of most practice deals. California's SB 351 prohibits hedge funds and private equity groups involved in business with any medical or dental practice from interfering with the professional judgment of physicians or dentists, among other limits.

What raises the multiple

Healthcare services businesses that attract competitive processes tend to share a few traits:

  • Clinicians who are not all near retirement, with an associate or partner bench that can absorb a departing owner's patient base.
  • A management services agreement that would survive a state corporate-practice review, with clinical authority clearly retained by licensed owners.
  • Clean billing and coding records, since coding and billing decisions are an area that California's SB 351 restricts private equity groups from controlling.
  • Above-average financial performance, with EBITDA margin and revenue growth both ahead of comparable practices.

Valuation and deal structure

There is no single public multiple for healthcare services. Smaller private deals generally price below larger private-equity deals, and single-site practice sales sit well below platform transactions. Sub-vertical, payer mix, and provider continuity move individual deals further from any sector average.

Deal timing now depends on regulators as well as buyers. California's AB 1415 requires private equity groups, hedge funds, and MSOs to provide 90 days' notice of agreements or transactions that transfer a material amount of a health care entity's assets or control. In Oregon, SB 951 becomes effective for new transactions starting January 1, 2026, and existing MSO relationships have until January 1, 2029 to comply.

Federal scrutiny persists. In March 2024 the FTC, DOJ, and HHS requested information on transactions that would not be reported to the Justice Department or FTC for antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act. The FTC's later settlement with Welsh Carson over its anesthesia roll-up included no monetary penalties, though Welsh Carson was forced to limit its involvement with USAP.

Subindustries

Consolidation stage differs sharply by vertical. Dentistry is the most mature practice roll-up, with 16% of U.S. dentists affiliated with a DSO as of 2024, while other verticals below sit at earlier or more regulated stages. Veterinary practices are among the most consolidated of those; if you own one, start with how to sell a veterinary practice. Ambulatory surgery centers sit at the physician-partnered end, covered in who buys ambulatory surgery centers.

Valuation multiples by subindustry: Dental Practices valuation multiples · Veterinary Practices valuation multiples · Physical Therapy & Rehab valuation multiples · Home Health & Hospice valuation multiples · Behavioral Health & Counseling valuation multiples · Dermatology & Medspa valuation multiples · Medical Billing & Revenue Cycle Management valuation multiples · Ambulatory Surgery Centers valuation multiples · Physician Practice Management (MSOs) valuation multiples · Pharmacy & Specialty Infusion valuation multiples · Labs & Diagnostics valuation multiples · Healthcare IT & Software valuation multiples

For owners: Selling a dental practice · Selling a veterinary practice · Selling a home health or hospice agency

Outlook

Expect a split market over the next 12-24 months. Bain says the stage is set for an active 2026 due to high levels of dry powder, and a lead healthcare analyst quoted by Advisory Board said “We expect mean reversion going forward.” after the 2026 slump.

The regulatory direction is toward more review, not less. In 2025, at least seven states enacted laws requiring greater oversight of PE healthcare acquisitions. As of mid-2025, at least 15 states had some form of healthcare transaction review law on the books, and more proposals were introduced in 2026. Owners selling into a PE-backed platform should expect state filings and corporate-practice review to add time to the process.


Own a healthcare practice and want a baseline before you talk to buyers? Run the valuation tool or read what dental buyers look for. See also: why vertical-specific buyers outperform generalists in outbound.

Frequently asked questions

What multiple do healthcare services businesses sell for?

Healthcare services businesses sell for a median 3.4x SDE with under $500K of SDE, rising to 12.9x EBITDA with $10M+ of EBITDA, in Axia Growth's analysis of 290 closed Healthcare-sector sales, the sector 8 of the 12 Healthcare Services guides map to. Most of those sales sit in the under $500K SDE band, where the middle half sold for 2.7x-4.2x SDE across 182 sales. The other 4 guides map to Professional Services, Business Services, Retail and Technology, with most-traded-band medians from 3.2x to 7.4x SDE. Updated October 28, 2026. Source: Axia Growth analysis of closed small-business sales, updated October 28, 2026.

What EBITDA multiple do healthcare services businesses sell for?

From $2M of EBITDA up, Healthcare-sector businesses sold for a median 5.1x at $2M-$3M (13 sales, middle half 3.1x-10.9x), 8.8x at $5M-$10M (14 sales, middle half 3.4x-10.7x) and 12.9x at $10M+ (17 sales, middle half 9.4x-18.5x). Below $2M, buyers price on SDE instead, so those multiples are lower and not comparable. Source: Axia Growth analysis of closed small-business sales, updated October 28, 2026.

Which Healthcare Services businesses sell for the highest multiple?

On each guide's most-traded size band, Healthcare IT & Software is highest at 7.4x SDE (Technology sector, Under $500K SDE) and Medical Billing & Revenue Cycle Management lowest at 3.2x SDE (Business Services sector, Under $500K SDE). Guides that map to the same sector share its figures. Source: Axia Growth analysis of closed small-business sales, updated October 28, 2026.

What is a healthcare services business worth?

In Axia Growth's analysis of closed small-business sales, 8 of the 12 Healthcare Services guides map to the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. There is no single figure for Healthcare Services as a whole; the table below gives each guide's headline band. According to Bain & Company, provider and related services deal value jumped 57% to an estimated $62 billion in 2025, while volume remained flat.

SDE or EBITDA: which applies to my healthcare services business?

Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size.

Which states require notice before a healthcare acquisition closes?

At least 15 states had some form of healthcare transaction review law as of mid-2025. California's AB 1415 requires private equity groups, hedge funds, and MSOs to give the state's Office of Health Care Affordability 90 days' notice of covered transactions. Sources: Health Capital Consultants; Crowell & Moring LLP.

Is the FTC still challenging private equity roll-ups in healthcare?

Yes, although enforcement has shifted toward settlements. The FTC settled with Welsh Carson in early 2025 over its U.S. Anesthesia Partners roll-up, a deal that included no monetary penalties, though Welsh Carson was forced to limit its involvement with USAP. Source: Healthcare Dive.

How do I get a value range for my business?

Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.

Sources

  1. Global healthcare private equity hits record $190 billion deal value in 2025--Bain & Company — Bain & Company (via PR Newswire), 2026-01-08 (accessed 2026-10-03)
  2. Around the nation: Private equity's healthcare pullback — Advisory Board (summarizing data reported by Fierce Healthcare), 2026-09-02 (accessed 2026-10-03)
  3. Private equity takeovers of physician groups down by half in 2026 — STAT, 2026-08-17 (accessed 2026-10-03)
  4. Federal Trade Commission, the Department of Justice and the Department of Health and Human Services Launch Cross-Government Inquiry on Impact of Corporate Greed in Health Care — Federal Trade Commission, 2024-03-05 (accessed 2026-10-03)
  5. FTC, US Anesthesia Partners reach settlement in Texas price collusion case — Healthcare Dive, 2025-09-10 (accessed 2026-10-03)
  6. States Intensify Healthcare PE Oversight — Health Capital Consultants, 2026-02 (accessed 2026-10-03)
  7. Oregon Enacts Strictest Legislative Barrier on Private Equity Transactions in Healthcare — Benesch, 2025-06-16 (accessed 2026-10-03)
  8. California Enacts New Requirements and Restrictions for Health Care Transactions — Crowell & Moring LLP, 2025-10 (accessed 2026-10-03)
  9. Dental practice research — American Dental Association Health Policy Institute, 2026 (accessed 2026-10-03)
  10. Heartland Dental Welcomes Foundation Dental Partners into Its Supported Network — Heartland Dental (via PR Newswire), 2026-10-02 (accessed 2026-10-03)

Cite this guide

Healthcare services businesses sell for a median 3.4x SDE with under $500K of SDE, rising to 12.9x EBITDA with $10M+ of EBITDA, in Axia Growth's analysis of 290 closed Healthcare-sector sales, the sector 8 of the 12 Healthcare Services guides map to. Most of those sales sit in the under $500K SDE band, where the middle half sold for 2.7x-4.2x SDE across 182 sales. The other 4 guides map to Professional Services, Business Services, Retail and Technology, with most-traded-band medians from 3.2x to 7.4x SDE. Updated October 28, 2026. Healthcare services businesses sold for a median 3.4x SDE under $500K up to 12.9x EBITDA at $10M+ in Axia Growth's analysis of 290 closed sales, by subindustry.

When using information from this guide, cite Axia Growth and link to this page.

Axia Growth. Healthcare Services M&A. Updated 2026-11-12. https://axiagrowth.com/resources/industries/healthcare

For buyers

Have a mandate in Healthcare Services? Share your buy box.

Share your buy box

For owners

Own a business in Healthcare Services? Book a confidential call.

Book a confidential call

For buyers

See who's in your buy box.

Submit your criteria

For owners

Thinking about selling?

Tell us about your business